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Methods

Background
• Delirium is a commonly encountered complication that typically occurs in
critically ill patients admitted to the intensive care unit (ICU)
• Delirium is an independent risk factor for poor short and long term outcomes as
there is a 10% increase in relative risk of morbidity in one year with each day of
delirium1
• The Society of Critical Care Medicine (SCCM) introduced the ICU Liberation
quality improvement initiative2
• The goal of this initiative is to “liberate” patients from the aspects of patient care
that may threaten the patient’s sense of self-worth
• In a pilot study, Barnes-Daley, et al. found that for every 10% increase in bundle
compliance, patients had 15% higher odds of hospital survival3
• The interventions recommended by the Liberation Bundle focus on assessment,
prevention, and management of delirium

The Confusion Assessment Method for the ICU (CAM-ICU) is a
validated assessment tool that is both sensitive and specific for
diagnosing delirium4

Design: Descriptive, single site interventional study, consisting of prospective data review
Duration: 8-12 weeks
Study Participants:
Inclusion
• Adult patients (age ≥ 18)
• Admitted to the medical or
cardiovascular ICU

Multicomponent, non-pharmacologic interventions are used for
prevention and management of delirium to help reduce modifiable risk
factors for delirium*

Prevention
Pharmacologic management with antipsychotics is only appropriate
when the patient is delirious AND displaying agitation or harmful
behaviors**

Purpose
• Lima Memorial Health System (LMHS) implemented a new LIBERATE protocol
to comply with the ICU Liberation Bundle and ensure the best patient outcomes in
the critical care areas
• Historically at LMHS, there has been no guidance on the assessment and
management of delirium
• The purpose of this study is to determine the effect of proper assessment,
prevention, and management of delirium on the ICU length of stay

Exclusion
• Pediatrics
• Pregnant or breast-feeding
• Antipsychotic use prior to
admission
• Documented lack of nonpharmacologic intervention

Interventions:

Assessment

*Examples: reorienting the patient, reducing sedation, enabling use of eye glasses
**Studies have demonstrated no difference in duration of delirium in non-agitated
patients who were managed without medication5

Study Design
Primary Outcome:
• Length of stay in the critical care unit

Management

• CAM-ICU conducted by nursing staff twice per shift
• A positive CAM-ICU triggers a notification to the attending
physician

• Multicomponent, non-pharmacologic interventions will be
implemented on all patients in critical care areas
• Nursing staff will document the interventions they incorporate
within the CAM-ICU assessment

• Delirious patients without agitation or worrisome behaviors will be
managed with non-pharmacologic intervention alone
• Patients with agitation or worrisome behaviors may receive
antipsychotics based on physician’s clinical judgement
• If deemed necessary, an order set with guideline recommended
options will be available*
*Mild agitation: haloperidol, quetiapine, risperidone, valproic acid
Severe agitation: dexmedetomidine

Education will be provided to two groups by the pharmacy resident:
1. Nursing staff on how to properly obtain a CAM-ICU score and the multicomponent
non-pharmacologic interventions they will ensure the patient is receiving daily
2. Physicians on the importance of optimizing multicomponent non-pharmacologic
interventions and on the appropriate use of the delirium order set

Secondary Outcomes:
• Mean daily sedative dose
• Total number of benzodiazepine doses
• Appropriate discontinuation of pharmacologic therapy used for delirium
• Duration of delirium
• Adverse reactions from pharmacologic intervention (eg. QTc prolongation)

Results
• Research ongoing
• Results will be presented at the Ohio Pharmacy Residency Conference in May
2019

Lima Memorial (Setting)
Affiliate: ProMedica (Toledo, OH)
Model Type: Non-profit Acute Care Community Hospital
Total Beds: 329
Average Daily Census: 100
Critical Care Beds: 24
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